Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Jul 10, 2026
ProShares UltraPro Russell 2000 (URTY) Delivers +13.7% as Small-Cap Rally Broadens

ProShares UltraPro Russell 2000 (URTY) Delivers +13.7% as Small-Cap Rally Broadens

Key Takeaways

  • URTY surged approximately 13.7% over the last 30 days, amplifying a powerful small-cap equity rally through its 3x daily leveraged exposure to the Russell 2000 Index.
  • The Russell 2000 completed its strongest first half since 1991, gaining 22% year-to-date, as the artificial intelligence investment cycle broadened beyond mega-cap technology companies into smaller suppliers and semiconductor equipment firms.
  • Over the last quarter, URTY delivered a substantially magnified return as the underlying index climbed more than 21% during the second quarter of 2026 alone.
  • Key catalysts included improving small-cap earnings estimates, a narrowing valuation gap versus large-cap stocks, and a US-brokered peace agreement with Iran that helped ease energy price pressures.
  • Semiconductor and semiconductor equipment names accounted for 16 of the Russell 2000's 50 best-performing stocks during the first half, directly benefiting URTY's leveraged exposure.

URTY ETF Overview and Portfolio Exposure

URTY is a leveraged exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to three times the daily performance of the Russell 2000 Index. The fund launched in February 2010, carries a net expense ratio of 0.95%, and manages approximately $352 million in net assets. It is designed as a short-term trading tool rather than a buy-and-hold investment, since daily compounding and leverage decay can cause returns over periods longer than one day to deviate significantly from three times the index return.

The Russell 2000 Index tracks roughly 1,900 to 2,000 small-capitalization US companies with an average market capitalization of about $1.5 billion to $1.8 billion. URTY obtains its leveraged exposure mainly through total return swap agreements with major financial institutions, along with a portfolio of individual small-cap holdings and futures contracts. Sector weightings in the underlying index are led by Financials at approximately 19.3%, followed by Industrials (17.1%), Health Care (16.0%), Information Technology (14.7%), and Consumer Discretionary (10.1%). This diversified small-cap mix means URTY’s performance is heavily influenced by domestic economic conditions, as small-cap companies typically generate 70% to 80% of their revenue inside the United States.

URTY Price Performance: Last 30 Days vs. the Quarter

Over the last 30 days, URTY climbed from a closing price of $72.70 on June 10, 2026, to approximately $82.69 as of July 10, 2026, representing a gain of roughly 13.7%. The move was not linear; the fund saw notable intra-period volatility, including a sharp rally in mid-June that pushed prices above $85, followed by a pullback in early July as profit-taking hit semiconductor names. The Russell 2000 itself reached a fresh all-time high above 3,046 during this window, providing strong tailwinds for the 3x leveraged fund.

Over the last quarter, performance was even more pronounced. The Russell 2000 Index gained approximately 21.5% during the second quarter of 2026 alone, its strongest quarterly showing in years. URTY, applying 3x daily leverage to that move, delivered a substantially magnified quarterly return. The three-month period captured a broad rotation into small-cap equities driven by improving earnings fundamentals, AI supply-chain expansion, and a favorable macroeconomic backdrop that included easing oil prices following diplomatic progress with Iran.

What Drove URTY Higher in the Last 30 Days

The primary driver of URTY’s 30-day advance was the continued outperformance of small-cap stocks relative to large-cap benchmarks. The Russell 2000’s rally was fueled by growing investor conviction that the artificial intelligence investment cycle is broadening well beyond the mega-cap technology companies that dominated market returns from 2023 through early 2025. Smaller semiconductor equipment manufacturers, testing companies, and specialized component suppliers have emerged as significant beneficiaries, with names such as AEHR (Aehr Test Systems), ICHR (Ichor Holdings), and MXL (MaxLinear) each surging more than 400% year-to-date.

Macroeconomic developments also provided support. The June nonfarm payrolls report showed only 57,000 jobs added against expectations of 115,000, which reduced near-term fears of additional Federal Reserve interest rate hikes. Lower rate expectations tend to benefit small-cap stocks, which generally carry more floating-rate debt than their large-cap counterparts. Additionally, the US-brokered peace agreement with Iran contributed to declining oil prices, a development that Invesco’s head of factor strategy noted could accelerate the profitability recovery for small-cap companies by reducing input and transportation costs.

Institutional flows into small-cap ETFs accelerated throughout the period, reflecting a structural rotation as the valuation gap between small and large caps narrowed from historically extreme levels. Consensus earnings growth estimates for Russell 2000 companies rose from approximately 23% to 38% during the first half of 2026, providing fundamental justification for the rally. I also checked sector leadership trends using Tickeron’s AI Screener to see how the small-cap names compared on momentum metrics.

What Drove URTY Performance Over the Last Quarter

The broader three-month trend reflects a structural regime change in US equity markets. After years of large-cap dominance, small-cap stocks began outperforming in early 2025, and that leadership accelerated through the second quarter of 2026. The Russell 2000 posted a 21.5% quarterly gain, with all 11 sectors finishing in positive territory. Information Technology was the standout sector, followed by Industrials, Health Care, and Financials, each making meaningful contributions to index performance.

Earnings growth has been the primary engine. Research from Royce Investment Partners indicates that more than 60% of the Russell 2000’s year-to-date and one-year returns through June 30 were attributable to earnings per share (EPS) growth rather than multiple expansion. This earnings-driven advance distinguishes the current rally from purely speculative episodes and has attracted institutional investors who had been underweight small-cap equities for much of the past decade. The AI buildout, which initially benefited only the largest technology companies, has progressively filtered through to smaller companies providing differentiated products and services across the semiconductor, energy, and construction segments of the AI supply chain.

AI Screener

Identifying ETFs and stocks with strong momentum or sector leadership can be challenging in fast-moving markets. Tickeron’s AI Screener is an AI-powered discovery platform that helps investors scan thousands of securities using technical indicators, fundamental metrics, volatility measures, AI-generated signals, and customizable industry filters. The platform enables users to surface trending securities, breakout candidates, and new trading opportunities more efficiently than manual screening. For investors seeking to monitor small-cap momentum, sector rotation patterns, or leveraged ETF opportunities, the AI Screener provides a structured, data-driven approach to idea generation. In my own process, this tool has been useful for quickly surfacing comparable names when evaluating leveraged small-cap exposure like URTY.

URTY ETF Outlook: What Investors Should Watch Next

Several factors will influence URTY’s trajectory over the coming months. The Federal Reserve’s interest rate path remains the most consequential variable for small-cap equities. While the soft June employment report reduced immediate tightening concerns, any upside surprises in inflation data or economic growth could revive rate hike expectations, disproportionately affecting leveraged small-cap exposure. Bank of America has estimated that every additional 25-basis-point rate increase reduces Russell 2000 operating earnings by approximately 2%.

The annual Russell index rebalancing, which took effect in late June, removed 43 of the index’s strongest-performing companies that graduated into the large-cap Russell 1000. Historical patterns suggest small-cap stocks have tended to give back a portion of their pre-rebalance outperformance in the weeks following the reshuffle. Additionally, the Russell 2000’s forward price-to-earnings ratio has expanded to approximately 26.4, exceeding the S&P 500’s multiple, which may temper further valuation-driven upside.

On the positive side, earnings growth estimates continue to be revised upward, and the AI investment cycle shows few signs of slowing. Small-cap valuations relative to large caps, while narrower than at the start of the year, remain below long-term averages on an enterprise-value-to-EBIT basis. Investors should also monitor geopolitical developments, energy prices, and the pace of AI-related capital expenditure, as these factors will directly affect the small-cap companies that increasingly drive URTY’s underlying index performance. As a 3x daily leveraged product, URTY is designed for short-term trading, and investors holding the fund for periods longer than a single trading session should monitor their positions closely given the effects of compounding and volatility decay. From what I see, these variables will determine whether the recent rotation sustains or pauses in the months ahead.

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: URTY

Contributor

My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.


URTY's Stochastic Oscillator stays in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

URTY moved above its 50-day moving average on August 21, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for URTY crossed bullishly above the 50-day moving average on August 07, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where URTY advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on URTY as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for URTY turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where URTY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

URTY broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for URTY entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are Bloom Energy Corp (NYSE:BE), Guardant Health (NASDAQ:GH), Arrowhead Pharmaceuticals (NASDAQ:ARWR), SSR Mining (NASDAQ:SSRM), Transocean Ltd (NYSE:RIG), Lumen Technologies (NYSE:LUMN), Valaris Limited (NYSE:VAL), Abercrombie & Fitch Co (NYSE:ANF), California Resources Corp (NYSE:CRC), Tanger (NYSE:SKT).

Industry description

The investment seeks daily investment results that correspond to three times (3x) the daily performance of the Russell 2000® Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of the small-cap segment of the U.S. markets. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

Market Cap

The average market capitalization across the ProShares UltraPro Russell2000 ETF is 2.58B. The market cap for tickers in the group ranges from 455.89K to 59.33B. BE holds the highest valuation in this group at 59.33B. The lowest valued company is ZSPC at 455.89K.

High and low price notable news

The average weekly price growth across all stocks in the ProShares UltraPro Russell2000 ETF was 117%. For the same ETF, the average monthly price growth was 140%, and the average quarterly price growth was 785%. HOWL experienced the highest price growth at 116%, while BRCC experienced the biggest fall at -90%.

Volume

The average weekly volume growth across all stocks in the ProShares UltraPro Russell2000 ETF was 11%. For the same stocks of the ETF, the average monthly volume growth was 2% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 56
Price Growth Rating: 51
SMR Rating: 74
Profit Risk Rating: 75
Seasonality Score: -21 (-100 ... +100)
View a ticker or compare two or three
URTY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Leveraged Equity
Address
ProShares Trust7501 Wisconsin Avenue,Suite 1000Bethesda
Phone
N/A
Web
www.proshares.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.